Application of Thromboelastography in Coagulation Dysfunction of Sepsis

  • Meini Jiang
Keywords: Thromboelastography; Sepsis; Coagulation dysfunction; Application analysis

Abstract

This article explores the clinical value of thromboelastography in coagulation dysfunction of sepsis patients. The
two groups were treated with routine fluid infusion, anti-infection and heparin anticoagulation. Compared with
the control group, the time of heparin use in the observation group (5.26 ± 0.95) days was shorter (P<0.05);
there was no statistical significance in the total use rate of heparin in the two groups (P> 0.05), but compared
with the control group, the 24-hour use rate of heparin in in the observation group (76.67%) was higher
(P<0.05); At the same time, compared with the control group, the length of stay in ICU in the observation group
was (10.24 ± 1.24) days shorter (P <0.05); and compared with the control group, the survival rate of the
observation group was (85.00%) higher in 28 days, and the incidence of DIC was (11.67%) lower (P < 0.05).
After using thromboelastography in coagulation dysfunction of patients with sepsis, we can judge the
hypercoagulable state of the body in early stage, guide the application of heparin in an all-round way, and give
appropriate and timely heparin treatment to patients can shorten the length of stay in ICU, reduce the incidence
of DIC and mortality of patients with sepsis in 28d, and improve the survival rate in 28d, which has a significant
clinical value.

Published
2020-05-01